Anti-PIEZO2 antibody [EPR27152-48]
- 20ul selling size
- Recombinant
- RabMAb
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal PIEZO2 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
C18orf30, C18orf58, FAM38B, Piezo-type mechanosensitive ion channel component 2, Protein FAM38B
- WB
Supplier Data
Western blot - Anti-PIEZO2 antibody [EPR27152-48] (AB318187)
Negative control : T-47D, MCF7.
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-PIEZO2 antibody [EPR27152-48] (ab318187) at 1/1000 dilution
Lane 1:
MKL-1 (human Skin Loosely packed floati aggregates with irregular outline and no central necrosis) whole cell lysate at 48 µg
Lane 2:
T-47D (human ductal breast epithelial tumor epithelial cell) whole cell lysate at 48 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 48 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 320 kDa,124 kDa
false
Exposure time: 92s
- WB
Supplier Data
Western blot - Anti-PIEZO2 antibody [EPR27152-48] (AB318187)
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-PIEZO2 antibody [EPR27152-48] (ab318187) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeting PIEZO2 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 320 kDa,124 kDa
false
Exposure time: 92s
Related conjugates and formulations (1)
-
Anti-PIEZO2 antibody [EPR27152-48] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PIEZO2 plays an important role in the sensory pathways of touch and proprioception. It is not a part of a larger protein complex but operates as a homotrimer. The channel's sensitivity to mechanical forces enables cells to transduce physical touch into electrical signals facilitating an organism's ability to perceive its environment.
Pathways
Sensory transduction and mechanotransduction heavily involve PIEZO2. This protein interacts within pathways that transmit information about mechanical loads to the nervous system. Although not directly part of larger pathways' cascades its role is well observed in touch-related signaling paths where it occasionally interacts with proteins like TRPV1.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
BMC musculoskeletal disorders 26:238 PubMed40069682
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com